gvtcx

Provision of Assay Kits for SCID Evaluation: EONIS-Q

NHS England Published 22 Apr 2026 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£395,807
Statuscomplete
Category (CPV) 85100000
Deadline31 Mar 2025
Contract start15 Oct 2025
Contract end31 Mar 2026
Procedureselective
SME suitableNo
OCIDocds-b5fd17-926f56f6-d6e9-4264-afad-0092df1cecfa

Award

SupplierValueDateStatus
Revvity (UK) Limited £949,937 21 Apr 2026 active

description

his request is for re-procurement same scope for 18 months, via a compliant Direct Ward National framework for the EONIS Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot for Severe Combined Immuno-Deficiency (SCID) in-service evaluation (ISE) in 4 Screening laboratories.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
22 Apr 2026 Award (award) · 8d0fb9d2-b9be-4e84-8f08-cdc60061b058-894110

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.